Studies related to Glycemic Control and Apple Cider Vinegar

The Effect Of Apple Vinegar Consumption On Glycemic Indices, Blood Pressure, Oxidative Stress, And Homocysteine In Patients With Type 2 Diabetes And Dyslipidemia: A Randomized Controlled Clinical Trial

Effect None
Values HOMA-IR. Mean + Sd. Apple cider vinegar: before 5.95 ± 3.05, after 3.17 ± 1.99. Control: before 5.68 ± 3.29, after 3.39 ± 1.92. QUICKI: Apple cider vinegar: before 0.30 ± 0.02, after 0.33 ± 0.03. Control: before 0.30 ± 0.02, after 0.32 ± 0.02
Trial Design Randomized trial
Trial Length 2-4 Weeks
Number of Subjects 70
Sex Female
Body Types Obese, Overweight, Average
Notes for this study:
In a randomized, unblinded trial, 70 type 2 diabetes patients were assigned to either 20 ml of apple cider vinegar daily or a control group for 4 weeks. Apple cider vinegar was to be taken in 10 ml doses at lunch and dinner.

Food records didn't suggest a notable difference in energy intake between groups. The apple cider vinegar group saw a notable reduction in fasting glucose, while the control group's levels increased, the difference being statistically significant. Insulin was reduced similarly in both groups, and HOMA-IR declined more in the apple cider vinegar group, but the difference wasn't statistically significant. There were also significantly greater reductions in malondialdehyde and increases in 2,20-Diphenyl-1- picrylhydrazyl levels in the apple cider vinegar group, while the control group saw greater reductions in blood pressure, though started out with considerably higher blood pressure.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.